Cernecka H[au] - Search Results

Year	Number of Results
2011	1
2012	3
2013	1
2014	4
2015	1
2016	1
2020	1
2021	1
2022	1

1

The odd sibling: features of β3-adrenoceptor pharmacology.

Cernecka H, Sand C, Michel MC. Cernecka H, et al. Mol Pharmacol. 2014 Nov;86(5):479-84. doi: 10.1124/mol.114.092817. Epub 2014 Jun 2. Mol Pharmacol. 2014. PMID: 24890609 Review.

2

TRPM2 Plays a Minor Role in AKI and Kidney Fibrosis.

Kurata Y, Tanaka T, Cernecka H, Eitner F, Nangaku M. Kurata Y, et al. Among authors: cernecka h. Kidney360. 2021 Oct 22;3(1):153-157. doi: 10.34067/KID.0005492021. eCollection 2022 Jan 27. Kidney360. 2021. PMID: 35368574 Free PMC article.

3

Cyclin-Dependent Kinase 18 Controls Trafficking of Aquaporin-2 and Its Abundance through Ubiquitin Ligase STUB1, Which Functions as an AKAP.

Dema A, Faust D, Lazarow K, Wippich M, Neuenschwander M, Zühlke K, Geelhaar A, Pallien T, Hallscheidt E, Eichhorst J, Wiesner B, Černecká H, Popp O, Mertins P, Dittmar G, von Kries JP, Klussmann E. Dema A, et al. Among authors: cernecka h. Cells. 2020 Mar 10;9(3):673. doi: 10.3390/cells9030673. Cells. 2020. PMID: 32164329 Free PMC article.

4

Specificity evaluation of antibodies against human β3-adrenoceptors.

Cernecka H, Ochodnicky P, Lamers WH, Michel MC. Cernecka H, et al. Naunyn Schmiedebergs Arch Pharmacol. 2012 Sep;385(9):875-82. doi: 10.1007/s00210-012-0767-6. Epub 2012 Jun 12. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22688595

5

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Dale PR, Cernecka H, Schmidt M, Dowling MR, Charlton SJ, Pieper MP, Michel MC. Dale PR, et al. Among authors: cernecka h. Curr Opin Pharmacol. 2014 Jun;16(100):31-42. doi: 10.1016/j.coph.2014.03.003. Epub 2014 Mar 27. Curr Opin Pharmacol. 2014. PMID: 24682092 Free PMC article. Review.

6

Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidates.

Michel MC, Cernecka H, Ochodnicky P. Michel MC, et al. Among authors: cernecka h. Eur J Pharmacol. 2011 Apr 25;657(1-3):1-3. doi: 10.1016/j.ejphar.2011.01.061. Epub 2011 Feb 12. Eur J Pharmacol. 2011. PMID: 21315709

7

Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction.

Cernecka H, Veizerova L, Mensikova L, Svetlik J, Krenek P. Cernecka H, et al. J Pharm Pharmacol. 2012 May;64(5):735-41. doi: 10.1111/j.2042-7158.2012.01466.x. Epub 2012 Feb 8. J Pharm Pharmacol. 2012. PMID: 22471370

8

Rat β₃-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues.

Cernecka H, Pradidarcheep W, Lamers WH, Schmidt M, Michel MC. Cernecka H, et al. Naunyn Schmiedebergs Arch Pharmacol. 2014 Nov;387(11):1117-27. doi: 10.1007/s00210-014-1039-4. Epub 2014 Aug 30. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 25172522

9

β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase.

Cernecka H, Kersten K, Maarsingh H, Elzinga CR, de Jong IJ, Korstanje C, Michel MC, Schmidt M. Cernecka H, et al. Naunyn Schmiedebergs Arch Pharmacol. 2015 Jul;388(7):749-59. doi: 10.1007/s00210-015-1128-z. Epub 2015 May 9. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 25956403 Free PMC article.

10

Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat.

Cernecka H, Doka G, Srankova J, Pivackova L, Malikova E, Galkova K, Kyselovic J, Krenek P, Klimas J. Cernecka H, et al. Eur J Pharmacol. 2016 Nov 15;791:244-253. doi: 10.1016/j.ejphar.2016.08.040. Epub 2016 Aug 31. Eur J Pharmacol. 2016. PMID: 27592051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results